These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 18665934

  • 1. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS.
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [Abstract] [Full Text] [Related]

  • 2. The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori.
    Song MJ, Park DI, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI.
    Helicobacter; 2010 Jun; 15(3):206-13. PubMed ID: 20557362
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY, Lee SW, Jung SW, Koo JS, Yim HJ, Park JJ, Chun HJ, Lee HS, Choi JH, Kim CD, Ryu HS.
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG, Lee DH, Ye BD, Lee KH, Kim BW, Kim SG, Kim SW, Kim SK, Kim JJ, Kim HY, Park JJ, Park CY, Baik GH, Lee YC, Lee JH, Lee JH, Chun HJ, Hahm KB, Hong SJ, Lee SW, Jung HC.
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [Abstract] [Full Text] [Related]

  • 5. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Cristiani F, Santi S, Rossi M, Marchi S.
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [Abstract] [Full Text] [Related]

  • 8. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
    Oh HS, Lee DH, Seo JY, Cho YR, Kim N, Jeoung SH, Kim JW, Hwang JH, Park YS, Lee SH, Shin CM, Cho HJ, Jung HC, Song IS.
    J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
    [Abstract] [Full Text] [Related]

  • 9. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [Abstract] [Full Text] [Related]

  • 10. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC, Chen JJ, Hu TH, Lu SN, Changchien CS.
    Hepatogastroenterology; 2005 Dec; 52(65):1617-21. PubMed ID: 16201128
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S.
    Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
    [Abstract] [Full Text] [Related]

  • 12. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
    Sánchez-Delgado J, Calvet X, Bujanda L, Gisbert JP, Titó L, Castro M.
    Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109
    [Abstract] [Full Text] [Related]

  • 13. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
    Sezikli M, Çetinkaya ZA, Güzelbulut F, Yeşil A, Coşgun S, Kurdaş OÖ.
    J Clin Pharm Ther; 2012 Jun; 37(3):282-5. PubMed ID: 21740452
    [Abstract] [Full Text] [Related]

  • 14. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, Rossi P, Gurnari M, Caracciolo F, Zippi M, Pica R.
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [Abstract] [Full Text] [Related]

  • 15. The effect of probiotics on Helicobacter pylori eradication.
    Park SK, Park DI, Choi JS, Kang MS, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI.
    Hepatogastroenterology; 2007 Dec; 54(79):2032-6. PubMed ID: 18251154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Kim YS, Kim SJ, Yoon JH, Suk KT, Kim JB, Kim DJ, Kim DY, Min HJ, Park SH, Shin WG, Kim KH, Kim HY, Baik GH.
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
    [Abstract] [Full Text] [Related]

  • 20. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study.
    Palmas F, Pellicano R, Massimetti E, Berrutti M, Fagoonee S, Rizzetto M.
    Panminerva Med; 2002 Jun; 44(2):145-7. PubMed ID: 12032434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.